does glp 1 cause kidney issues Glucagon-like Peptide-1 Receptor Agonists and Diabetic Disease: From Bench to Bed-Side The GLP-1 Era: Why These

Taber DJ, Meadows HB, Pilch NA, Chavin KD, Baliga PK, Egede LE

Professor Richard Weller, Professor of Medical Dermatology at the University of Edinburgh and Honorary Consultant Dermatologist, added, Atopic dermatitis, a lifelong condition without a cure, greatly benefits from the expanding range of biologic treatments like lebrikizumab, now reimbursed by NICE, thereby enhancing treatment options for patients. NICEs endorsement of lebrikizumab represents a pivotal development in the treatment landscape for moderate to severe Atopic Dermatitis, offering hope for improved quality of life for many affected individuals.

Weimheim: Verlag Chemie

doi: 10.1007/s10067-025-07637-z